Access the full text.
Sign up today, get DeepDyve free for 14 days.
KA Yoon, JL Ku, HK Yang, WH Kim, SY Park, JG Park (1999)
Germline mutations of E-cadherin gene in Korean familial gastric cancer patientsJ Hum Genet, 44
P Guilford, J Hopkins, J Harraway (1998)
E-cadherin germline mutations in familial gastric cancerNature, 392
C Oliveira, J Senz, P Kaurah (2009)
Germline CDH1 deletions in hereditary diffuse gastric cancer familiesHum Mol Genet, 18
CV Moura Gallo, ESMG Azevedo, E Moraes, M Olivier, P Hainaut (2005)
TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectivesMutat Res, 589
CD Mathers, D Loncar (2006)
Projections of global mortality and burden of disease from 2002 to 2030PLoS Med, 3
RC Fitzgerald, R Hardwick, D Huntsman (2010)
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future researchJ Med Genet, 47
HC Kim, JM Wheeler, JC Kim (2000)
The E-cadherin gene (CDH1) variants T340A and L599 V in gastric and colorectal cancer patients in KoreaGut, 47
F Roviello, G Corso, C Pedrazzani (2007)
High incidence of familial gastric cancer in Tuscany, a region in ItalyOncology, 72
AR Brooks-Wilson, P Kaurah, G Suriano (2004)
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteriaJ Med Genet, 41
G Keller, H Vogelsang, I Becker (2004)
Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patientsJ Med Genet, 41
S Lim, HS Lee, HS Kim, YI Kim, WH Kim (2003)
Alteration of E-cadherin-mediated adhesion protein is common, but microsatellite instability is uncommon in young age gastric cancersHistopathology, 42
S Kim, CS Ki, KM Kim, MG Lee, JM Bae, JW Kim (2011)
Novel mechanism of a CDH1 splicing mutation in a Korean patient with signet ring cell carcinomaBMB Rep, 44
BA Jonsson, A Bergh, P Stattin, M Emmanuelsson, H Gronberg (2002)
Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancerInt J Cancer, 98
P Kaurah, A MacMillan, N Boyd (2007)
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancerJAMA, 297
IJ Kim, HC Kang, Y Shin (2004)
A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndromeJ Hum Genet, 49
G Suriano, S Yew, P Ferreira (2005)
Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical managementClin Cancer Res, 11
H Yamada, K Shinmura, H Ito (2011)
Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese populationCancer Sci, 102
JB Koea, MS Karpeh, MF Brennan (2000)
Gastric cancer in young patients: demographic, clinicopathological, and prognostic factors in 92 patientsAnn Surg Oncol, 7
G Suriano, C Oliveira, P Ferreira (2003)
Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probandsHum Mol Genet, 12
IJ Kim, JH Park, HC Kang (2003)
A novel germline mutation in the MET extracellular domain in a Korean patient with the diffuse type of familial gastric cancerJ Med Genet, 40
C Caldas, F Carneiro, HT Lynch (1999)
Familial gastric cancer: overview and guidelines for managementJ Med Genet, 36
JH Lee, SU Han, H Cho (2000)
A novel germ line juxtamembrane Met mutation in human gastric cancerOncogene, 19
G Corso, C Pedrazzani, H Pinheiro (2011)
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancerEur J Cancer, 47
C Oliveira, P Ferreira, S Nabais (2004)
E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patientsEur J Cancer, 40
H More, B Humar, W Weber (2007)
Identification of seven novel germline mutations in the human E-cadherin (CDH1) geneHum Mutat, 28
P Lauren (1965)
The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classificationActa Pathol Microbiol Scand, 64
F Carneiro, C Oliveira, G Suriano, R Seruca (2008)
Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancerJ Clin Pathol, 61
K Umeyama, M Sowa, K Kamino, Y Kato, K Satake (1982)
Gastric carcinoma in young adults in JapanAnticancer Res, 2
A Ramos-De la Medina, N Salgado-Nesme, G Torres-Villalobos, H Medina-Franco (2004)
Clinicopathologic characteristics of gastric cancer in a young patient populationJ Gastrointest Surg, 8
M Bernini, S Barbi, F Roviello (2006)
Family history of gastric cancer: a correlation between epidemiologic findings and clinical dataGastric Cancer, 9
G Corso, D Marrelli, V Pascale, C Vindigni, F Roviello (2012)
Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literatureBMC Cancer, 12
The impact of CDH1 gene mutations and large deletions on hereditary diffuse gastric cancer (HDGC) and early onset diffuse gastric cancer (EODGC) has not been determined in Asians. We investigated the mutation status of the CDH1 gene in 25 Korean EODGC patients younger than 50 years and 23 HDGC patients who met the clinical criteria for HDGC. Polymerase chain reaction-direct sequencing was performed, and multiplex ligation-dependent probe amplification (MLPA) was used to evaluate the patients with negative sequencing results. We determined that 2 of 25 (8 %) EODGC patients had CDH1 germline mutations. One was a nonsense mutation (c.1003C>T, p.Arg335*, exon 7) in a 41-year-old female with no family history of cancer. The other was a missense mutation (c.715G>A, p.Gly239Arg, exon 6) in a 28-year-old male with no family history of cancer. One of 23 (4.3 %) HDGC patients had a CDH1 germline mutation (c.1003C>T). The patient’s brother and sister died of stomach cancer. The MLPA results revealed no deletion or duplication in any patient. More research is needed to determine additional genetic targets that trigger HDGC. More comprehensive methods such as next-generation sequencing might be a good approach that can be used to identify the genetic causes of pathogenetically unexplained disorders.
Familial Cancer – Springer Journals
Published: Dec 21, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.